300006.SZ · 莱美药业
China A-shares · RS rating 98 · As of 2026-10-14
| Price | 7.90 CNY |
|---|---|
| 1-day change | +20.1% |
| RS rating (overall / 1M / 3M / 12M) | 98 / 99 / 98 / 95 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 57 / 53 / 35 |
| Industry group (rank) | Medical-Products (64) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -7.7% |
| Distance from 52-week high | +0.0% |
| Market cap (USD) | $863.8M |